BIS was created on 2010-04-07 by ProShares. The fund's investment portfolio concentrates primarily on health care equity. BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.
What is the current price of ProShares UltraShort Nasdaq Biotechnology (BIS)?
The current price of ProShares UltraShort Nasdaq Biotechnology (BIS) is 10.59. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of ProShares UltraShort Nasdaq Biotechnology?
The 52-week high of ProShares UltraShort Nasdaq Biotechnology is 18.11. Please refer to the page timestamp for the latest data.
What is the 52-week low of ProShares UltraShort Nasdaq Biotechnology?
The 52-week low of ProShares UltraShort Nasdaq Biotechnology is 10.75. Please refer to the page timestamp for the latest data.
What is the NAV of ProShares UltraShort Nasdaq Biotechnology?
The NAV of ProShares UltraShort Nasdaq Biotechnology is 11.47 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is ProShares UltraShort Nasdaq Biotechnology (BIS) performing?
The trading turnover of ProShares UltraShort Nasdaq Biotechnology (BIS) is 15.14K. Its price changed by -12.04% over the past month, while its one-year return is -50.23%. View the ProShares UltraShort Nasdaq Biotechnology price chart for more details.
Is ProShares UltraShort Nasdaq Biotechnology (BIS) a safe investment?
No investment is completely risk-free. The risk level of ProShares UltraShort Nasdaq Biotechnology (BIS) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.